Yari Ciani (@YariCiani) header
Yari Ciani (@YariCiani) profile picture

PhD, Laboratory of Computational and Functional Oncology, CIBIO, University of Trento

Joined February 2012
Photo by Yari Ciani (@YariCiani)Photo by Yari Ciani (@YariCiani)Photo by Yari Ciani (@YariCiani)Photo by Yari Ciani (@YariCiani)Photo by Yari Ciani (@YariCiani)Photo by Yari Ciani (@YariCiani)Photo by Yari Ciani (@YariCiani)Photo by Yari Ciani (@YariCiani)Photo by Yari Ciani (@YariCiani)
Does changing the reference genome from hg38 to T2T-CHM13 affect mapping over clinically relevant variants? We show that the T2T-CHM13 reference genome reduces bias in human sequence analysis with implications for variant discovery and clinical genomics.biorxiv.org/content/10.64898…
1
1
2
58
· Reference genome assembly choice impacts the detection of clinically relevant variants , including pathogenic variants in BRCA1 gene
1
18
In light of our results, we support the implementation of the T2T-CHM13 reference for the improvement of sequencing data analyses in the clinical genomic setting. DemichelisLab (@FrancescaBZNY) @CIBIO_UniTrento @UniTrento
18
Favorite study! Germline-somatic tandems dictate cancer subtypes, provide clinical insights, and fuel molecularly informed studies. Kudos: Blerta Stringa, @Paola_Gasperini, Alessandro Alaimo, and @LunardiLabCIBIO (co-last a!) @NimaSharifiMD doi.org/10.1158/2159-8290.CD… @UniTrento
3
16
1
38
2,999
🔥Post-doc position open🔥 at the Demichelis laboratory @UniTrento ⏳ application by August 31st! 👉 more info evitasociety.org/index.php/a… #oncosome #prostatecancer #evitians @CaterinaNardel1 @FrancescaBZNY
3
3
280
In our research group at DemichelisLab (@FrancescaBZNY) we are currently working on plasma-derived EVs from prostate cancer patients: works like the one from @IcasanovaSalas are a treasure trove both for biomarker discovery/validation and for generating new hypotheses.
1
1
72
Many thanks to @CancerCell for the opportunity, to @FrancescaBZNY and @CaterinaNardel1 for the invaluable help and pristine writing, and @AIRC_it for the financial support.
62
Casanova-Salas and colleagues analyze cfDNA, EV-DNA, and EV-RNA in prostate cancer longitudinal cohorts and identify signals of tumor adaptation to androgen receptor signaling inhibitors or taxanes treatment. doi.org/10.1016/j.ccell.2024…
74
I had the honor of writing a preview of the article published by @ICasanovaSalas et al. in the latest issue of @Cancer_Cell . doi.org/10.1016/j.ccell.2024…
2
1
1
237
🥂🙌 A new doctor, Thomas Cantore, Ph.D. @cantore_thomas in the Computational and Functional Oncology DemichelisLab! #PRODE @CIBIO_UniTrento @paola_gasperini @YariCiani @MariannKruithof @NCIEytanRuppin
3
4
33
2,059
I am beyond excited to see our work out in @CD_AACR . We established a targeted sequencing assay to non-invasively monitor treatment resistance in advanced prostate cancer. Want to know more? Let’s take a short walk 👣 aacrjournals.org/cancerdisco…
2
10
4
37
6,649
👏Read in #JExBio👏These authors developed and assessed ONCE (One Aliquot for Circulating Elements), an approach for the isolation of EVs and cfDNA from a single aliquot of blood. #liquidbiopsies Read it here 👉onlinelibrary.wiley.com/doi/…
6
15
1,831
DemichelisLab and collaborators’ work on #singlealiquot #cfDNA & #EV-RNA leveraging ONCE is out in Journal of Extracellular Biology. It shows enhanced performance in detecting HER2+ in neo-adjuvant breast cancer plasmas. @AIRC_it @CR_UK @Fond.Caritro @ApssTn
1
4
164
We currently apply the methodology also to metastatic prostate cancer patients' liquid biopsy to study treatment resistance as part of the #PRIME program funded by @AIRC_it @CR_UK More to come! @FrancescaBZNY @CaterinaNardel1 @vera_mugoni @IsevOrg @DoloresDiVizio @CIBIO_UniTrento
1
2
79